List of Tables
    Table 1. Solid Tumors Drugs CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Solid Tumors Drugs Market Trends
    Table 3. Solid Tumors Drugs Market Drivers
    Table 4. Solid Tumors Drugs Market Challenges
    Table 5. Solid Tumors Drugs Market Restraints
    Table 6. Global Solid Tumors Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Solid Tumors Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Solid Tumors Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Solid Tumors Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Solid Tumors Drugs Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Solid Tumors Drugs Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Solid Tumors Drugs Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Solid Tumors Drugs Sales by Manufacturer, (K Pcs), 2017-2022
    Table 14. Global Solid Tumors Drugs Sales Share by Manufacturer, 2017-2022
    Table 15. Global Solid Tumors Drugs Price by Manufacturer (2017-2022) & (USD/Pcs)
    Table 16. Global Solid Tumors Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Solid Tumors Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Solid Tumors Drugs as of 2021)
    Table 18. Top Players of Solid Tumors Drugs in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Solid Tumors Drugs Product Type
    Table 20. Date of International Manufacturers Enter into Solid Tumors Drugs Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Solid Tumors Drugs Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Solid Tumors Drugs Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Solid Tumors Drugs Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Solid Tumors Drugs Sales by Players, (K Pcs), 2020, 2021 & 2022
    Table 26. United States Solid Tumors Drugs Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Solid Tumors Drugs Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Solid Tumors Drugs Sales in Volume by Region (2017-2022) & (K Pcs)
    Table 29. Global Solid Tumors Drugs Sales in Volume Forecast by Region (2023-2028) & (K Pcs)
    Table 30. Global Solid Tumors Drugs Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Solid Tumors Drugs Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Solid Tumors Drugs Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 33. North America Solid Tumors Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Solid Tumors Drugs Sales in Volume by Region (2017-2028) & (K Pcs)
    Table 35. Asia Pacific Solid Tumors Drugs Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Solid Tumors Drugs Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 37. Europe Solid Tumors Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Solid Tumors Drugs Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 39. Latin Americaa Solid Tumors Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Solid Tumors Drugs Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 41. Middle East and Africa Solid Tumors Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Hoffmann-La Roche Corporation Information
    Table 43. Hoffmann-La Roche Description and Business Overview
    Table 44. Hoffmann-La Roche Solid Tumors Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 45. Hoffmann-La Roche Solid Tumors Drugs Product
    Table 46. Hoffmann-La Roche Recent Development
    Table 47. Novartis Corporation Information
    Table 48. Novartis Description and Business Overview
    Table 49. Novartis Solid Tumors Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 50. Novartis Product
    Table 51. Novartis Recent Development
    Table 52. Celgene Corporation Information
    Table 53. Celgene Description and Business Overview
    Table 54. Celgene Solid Tumors Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 55. Celgene Product
    Table 56. Celgene Recent Development
    Table 57. Johnson & Johnson Corporation Information
    Table 58. Johnson & Johnson Description and Business Overview
    Table 59. Johnson & Johnson Solid Tumors Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 60. Johnson & Johnson Product
    Table 61. Johnson & Johnson Recent Development
    Table 62. Pfizer Corporation Information
    Table 63. Pfizer Description and Business Overview
    Table 64. Pfizer Solid Tumors Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 65. Pfizer Product
    Table 66. Pfizer Recent Development
    Table 67. BMS Corporation Information
    Table 68. BMS Description and Business Overview
    Table 69. BMS Solid Tumors Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 70. BMS Product
    Table 71. BMS Recent Development
    Table 72. Eli Lilly Corporation Information
    Table 73. Eli Lilly Description and Business Overview
    Table 74. Eli Lilly Solid Tumors Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 75. Eli Lilly Product
    Table 76. Eli Lilly Recent Development
    Table 77. GSK Corporation Information
    Table 78. GSK Description and Business Overview
    Table 79. GSK Solid Tumors Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 80. GSK Product
    Table 81. GSK Recent Development
    Table 82. Merck Corporation Information
    Table 83. Merck Description and Business Overview
    Table 84. Merck Solid Tumors Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 85. Merck Product
    Table 86. Merck Recent Development
    Table 87. Sanofi Corporation Information
    Table 88. Sanofi Description and Business Overview
    Table 89. Sanofi Solid Tumors Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 90. Sanofi Product
    Table 91. Sanofi Recent Development
    Table 92. AbbVie Corporation Information
    Table 93. AbbVie Description and Business Overview
    Table 94. AbbVie Solid Tumors Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 95. AbbVie Product
    Table 96. AbbVie Recent Development
    Table 97. AstraZeneca Corporation Information
    Table 98. AstraZeneca Description and Business Overview
    Table 99. AstraZeneca Solid Tumors Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 100. AstraZeneca Product
    Table 101. AstraZeneca Recent Development
    Table 102. Bayer Corporation Information
    Table 103. Bayer Description and Business Overview
    Table 104. Bayer Solid Tumors Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 105. Bayer Product
    Table 106. Bayer Recent Development
    Table 107. Biogen Corporation Information
    Table 108. Biogen Description and Business Overview
    Table 109. Biogen Solid Tumors Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 110. Biogen Product
    Table 111. Biogen Recent Development
    Table 112. Boehringer Ingelheim Corporation Information
    Table 113. Boehringer Ingelheim Description and Business Overview
    Table 114. Boehringer Ingelheim Solid Tumors Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 115. Boehringer Ingelheim Product
    Table 116. Boehringer Ingelheim Recent Development
    Table 117. Boston Biomedical Corporation Information
    Table 118. Boston Biomedical Description and Business Overview
    Table 119. Boston Biomedical Solid Tumors Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 120. Boston Biomedical Product
    Table 121. Boston Biomedical Recent Development
    Table 122. Daiichi Sankyo Corporation Information
    Table 123. Daiichi Sankyo Description and Business Overview
    Table 124. Daiichi Sankyo Solid Tumors Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 125. Daiichi Sankyo Product
    Table 126. Daiichi Sankyo Recent Development
    Table 127. Key Raw Materials Lists
    Table 128. Raw Materials Key Suppliers Lists
    Table 129. Solid Tumors Drugs Customers List
    Table 130. Solid Tumors Drugs Distributors List
    Table 131. Research Programs/Design for This Report
    Table 132. Key Data Information from Secondary Sources
    Table 133. Key Data Information from Primary Sources
List of Figures
    Figure 1. Solid Tumors Drugs Product Picture
    Figure 2. Global Solid Tumors Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Solid Tumors Drugs Market Size 2017-2028 (US$ Million)
    Figure 4. Global Solid Tumors Drugs Sales 2017-2028 (K Pcs)
    Figure 5. United States Solid Tumors Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Solid Tumors Drugs Market Size 2017-2028 (US$ Million)
    Figure 7. United States Solid Tumors Drugs Sales 2017-2028 (K Pcs)
    Figure 8. United States Solid Tumors Drugs Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Solid Tumors Drugs Market Share in Global, in Volume (K Pcs) 2017-2028
    Figure 10. Solid Tumors Drugs Report Years Considered
    Figure 11. Product Picture of Small Molecules
    Figure 12. Product Picture of Biologics
    Figure 13. Global Solid Tumors Drugs Market Share by Type in 2022 & 2028
    Figure 14. Global Solid Tumors Drugs Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 15. Global Solid Tumors Drugs Sales Market Share in Value by Type (2017-2028)
    Figure 16. Global Solid Tumors Drugs Sales by Type (2017-2028) & (K Pcs)
    Figure 17. Global Solid Tumors Drugs Sales Market Share in Volume by Type (2017-2028)
    Figure 18. Global Solid Tumors Drugs Price by Type (2017-2028) & (USD/Pcs)
    Figure 19. United States Solid Tumors Drugs Market Share by Type in 2022 & 2028
    Figure 20. United States Solid Tumors Drugs Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 21. United States Solid Tumors Drugs Sales Market Share in Value by Type (2017-2028)
    Figure 22. United States Solid Tumors Drugs Sales by Type (2017-2028) & (K Pcs)
    Figure 23. United States Solid Tumors Drugs Sales Market Share in Volume by Type (2017-2028)
    Figure 24. United States Solid Tumors Drugs Price by Type (2017-2028) & (USD/Pcs)
    Figure 25. Product Picture of Hospitals
    Figure 26. Product Picture of Clinics
    Figure 27. Product Picture of Academic and Research Institutes
    Figure 28. Product Picture of Others
    Figure 29. Global Solid Tumors Drugs Market Share by Application in 2022 & 2028
    Figure 30. Global Solid Tumors Drugs Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 31. Global Solid Tumors Drugs Sales Market Share in Value by Application (2017-2028)
    Figure 32. Global Solid Tumors Drugs Sales by Application (2017-2028) & (K Pcs)
    Figure 33. Global Solid Tumors Drugs Sales Market Share in Volume by Application (2017-2028)
    Figure 34. Global Solid Tumors Drugs Price by Application (2017-2028) & (USD/Pcs)
    Figure 35. United States Solid Tumors Drugs Market Share by Application in 2022 & 2028
    Figure 36. United States Solid Tumors Drugs Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 37. United States Solid Tumors Drugs Sales Market Share in Value by Application (2017-2028)
    Figure 38. United States Solid Tumors Drugs Sales by Application (2017-2028) & (K Pcs)
    Figure 39. United States Solid Tumors Drugs Sales Market Share in Volume by Application (2017-2028)
    Figure 40. United States Solid Tumors Drugs Price by Application (2017-2028) & (USD/Pcs)
    Figure 41. North America Solid Tumors Drugs Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 42. North America Solid Tumors Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 43. U.S. Solid Tumors Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Canada Solid Tumors Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Europe Solid Tumors Drugs Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 46. Europe Solid Tumors Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 47. Germany Solid Tumors Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. France Solid Tumors Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. U.K. Solid Tumors Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Italy Solid Tumors Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Russia Solid Tumors Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Asia-Pacific Solid Tumors Drugs Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 53. Asia-Pacific Solid Tumors Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 54. China Solid Tumors Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Japan Solid Tumors Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. South Korea Solid Tumors Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. India Solid Tumors Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Australia Solid Tumors Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Taiwan Solid Tumors Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Indonesia Solid Tumors Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Thailand Solid Tumors Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Malaysia Solid Tumors Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Philippines Solid Tumors Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Latin America Solid Tumors Drugs Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 65. Latin America Solid Tumors Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 66. Mexico Solid Tumors Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Brazil Solid Tumors Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Argentina Solid Tumors Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 69. Middle East & Africa Solid Tumors Drugs Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 70. Middle East & Africa Solid Tumors Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 71. Turkey Solid Tumors Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. Saudi Arabia Solid Tumors Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. U.A.E Solid Tumors Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 74. Solid Tumors Drugs Value Chain
    Figure 75. Solid Tumors Drugs Production Process
    Figure 76. Channels of Distribution
    Figure 77. Distributors Profiles
    Figure 78. Bottom-up and Top-down Approaches for This Report
    Figure 79. Data Triangulation
    Figure 80. Key Executives Interviewed